everytraceeverytraceeverytraceeverytrace
all names

Pierre Fabre person

Named in 2 reports across 1 story - 8 Sept – 29 Oct
8 Sept 202629 Oct 2026

The web around Pierre Fabre

Closest companions, sized by how often they share a report with Pierre Fabre. Lines between the outer names are their own relationships - names that appear together even without Pierre Fabre.

Bayer Pharma and Cancer Research United Kingdom share 1 reportBoehringer Ingelheim and Cancer Research United Kingdom share 1 reportBayer Pharma and Boehringer Ingelheim share 1 reportAstrazeneca and Bayer Pharma share 1 reportDebiopharm International and Eli Lilly share 1 reportAstrazeneca and Daiichi Sankyo share 1 reportAmgen and Cancer Research United Kingdom share 1 reportAmgen and Daiichi Sankyo share 1 reportCancer Research United Kingdom and Debiopharm International share 1 reportBristol Myers Squibb and Debiopharm International share 1 reportAmgen and Eli Lilly share 1 reportBoehringer Ingelheim and Daiichi Sankyo share 1 reportAmgen and Bayer Pharma share 1 reportBoehringer Ingelheim and Eli Lilly share 1 reportAmgen and Boehringer Ingelheim share 1 reportBoehringer Ingelheim and Bristol Myers Squibb share 1 reportAmgen and Bristol-Myers Squibb share 1 reportBristol-Myers Squibb and Eli Lilly share 1 reportDaiichi Sankyo and Eli Lilly share 1 reportBoehringer Ingelheim and Debiopharm International share 1 reportBristol-Myers Squibb and Daiichi Sankyo share 1 reportAstrazeneca and Bristol-Myers Squibb share 1 reportBristol Myers Squibb and Eli Lilly share 1 reportBayer Pharma and Bristol Myers Squibb share 1 reportBristol Myers Squibb and Bristol-Myers Squibb share 1 reportAmgen and Astrazeneca share 1 reportAstrazeneca and Debiopharm International share 1 reportBayer Pharma and Daiichi Sankyo share 1 reportAmgen and Debiopharm International share 1 reportDaiichi Sankyo and Debiopharm International share 1 reportBristol-Myers Squibb and Cancer Research United Kingdom share 1 reportBristol Myers Squibb and Cancer Research United Kingdom share 1 reportBoehringer Ingelheim and Bristol-Myers Squibb share 1 reportAmgen and Bristol Myers Squibb share 1 reportBayer Pharma and Debiopharm International share 1 reportAstrazeneca and Boehringer Ingelheim share 1 reportBayer Pharma and Eli Lilly share 1 reportBristol Myers Squibb and Daiichi Sankyo share 1 reportBayer Pharma and Bristol-Myers Squibb share 1 reportCancer Research United Kingdom and Eli Lilly share 1 reportPierre FabreAmgenAmgen - 1 shared report (organization)AstrazenecaAstrazeneca - 1 shared report (organization)Bayer PharmaBayer Pharma - 1 shared report (person)Boehringer …Boehringer Ingelheim - 1 shared report (organization)Bristol Mye…Bristol Myers Squibb - 1 shared report (organization)Bristol-Myers Squ…Bristol-Myers Squibb - 1 shared report (person)Cancer Rese…Cancer Research United Kingdom - 1 shared report (organization)Daiichi San…Daiichi Sankyo - 1 shared report (person)Debiopharm …Debiopharm International - 1 shared report (organization)Eli LillyEli Lilly - 1 shared report (organization)

The stories

Biofrontera Inc. to Report Second Quarter 2026 Financial Results on August 13, 2026

73 outlets2 reports name Pierre Fabre5 Aug – 3 Nov

People they appear with

Bayer Pharma1Bristol-Myers Squibb1Daiichi Sankyo1Exeter Pharma1Innoup Farma1

Organisations in the same coverage

Amgen1Astrazeneca1Boehringer Ingelheim1Bristol Myers Squibb1Cancer Research United Kingdom1Debiopharm International1Eli Lilly1Genentech1Glaxosmithkline1Health Systems1Indian Health Service1Lovell Government Services1Nant Capital1Novartis1

Who keeps naming them

rttnews.com1onclive.com1

One email a week

The stories everytrace watched stay alive - how many independent outlets carried each one, and how long it lasted. No daily digest, no breaking-news alerts.